The Increasing Occurrence of Infectious Diseases in Childhood: Is It Linked with Declining Vaccination Rates Across Society?
DOI:
https://doi.org/10.12775/JEHS.2024.74.52556Keywords
measles, pertussis, rubella, vaccination, hib, infectious diseasesAbstract
Introduction. Childhood infectious diseases have been a significant medical problem, with a global increase in recent years. Modern diagnostic methods and new vaccinations are available. Poland is part of the WHO-coordinated global measles and rubella elimination program. Controversy surrounds mandatory and recommended vaccinations in Poland. There has been a concerning increase in the abandonment of vaccinating children, leading to a resurgence of infectious diseases. In 2024, the WHO reported a significant increase in measles cases in the European region, including in Poland. It's crucial to remind people of these diseases and warn them about the complications they bring.
Aim of study. The aim of this study is to investigate the increasing occurrence of infectious diseases in childhood and examine the correlation with declining vaccination rates across society.
Materials and methods. An unsystematic review of scientific literature was conducted, employing specific keywords such as „measles,” „pertussis,” „rubella,” „infectious diseases,” „vaccination,” and „hib.” The review was executed on the PubMed database, analyzing a total of 59 sources published until the conclusion of 2024.
Conclusions. To control and eliminate infectious diseases, it is vital to maintain and improve vaccination rates. Policymakers and healthcare providers should prioritize immunization programs and address barriers to vaccine access. Further research is crucial to develop comprehensive strategies for increasing vaccination coverage and understanding vaccine-preventable diseases in modern public health challenges.
References
A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action, https://www.who.int/europe/news/item/14-12-2023-a-30-fold-rise-of-measles-cases-in-2023-in-the-who-european-region-warrants-urgent-action
Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy Zakład Epidemiologii Chorób Zakaz´nych i Nadzoru, Główny Inspektorat Sanitarny Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic, Vaccinations in Poland in 2022, Warszawa 2023
Meldunki o zachorowaniach na choroby zakaźne, zakażeniach i zatruciach w Polsce (dwutygodniowe), https://wwwold.pzh.gov.pl/oldpage/epimeld/index_p.html#01
Anderso RM, May RM. Immunisation and herd immunity. Lancet 1990;335:641-645
GŁOWACKA, Katarzyna; FABIAN-DANIELEWSKA, Anna. Measles-a disease that should be a thing of the past, but returns. Journal of Education, Health and Sport, 2019, 9.4: 543-548.
BATTEGAY, Raphael; ITIN, Christoph; ITIN, Peter. Dermatological signs and symptoms of measles: a prospective case series and comparison with the literature. Dermatology, 2012, 224.1: 1-4.
ROBBINS, Frederick C. Measles: clinical features: pathogenesis, pathology and complications. American Journal of Diseases of Children, 1962, 103.3: 266-273.
O’DONNELL, Shaun, et al. Could this be measles?. Emergency Medicine Journal, 2019, 36.5: 310-314.
GARG, Ravindra Kumar, et al. Subacute sclerosing panencephalitis. Reviews in medical virology, 2019, 29.5: e2058.
VIETH, M., et al. Acute measles gastric infection. The American journal of surgical pathology, 2001, 25.2: 259-262.
LOUKIDES, S., et al. Bacterial pneumonia as a suprainfection in young adults with measles. European Respiratory Journal, 1999, 13.2: 356-360.
PATTERSON, Marc C. Neurological complications of measles (rubeola). Current Neurology and Neuroscience Reports, 2020, 20: 1-8.
BEN-CHETRIT, Eli, et al. Measles-related hospitalizations and associated complications in Jerusalem, 2018–2019. Clinical Microbiology and Infection, 2020, 26.5: 637-642.
MCLEAN, Huong Q., et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2013, 62.RR-04: 1-34.
SIMONS, Emily, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. The Lancet, 2012, 379.9832: 2173-2178.
VAN DEN ENT, Maya MVX, et al. Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990–2008. The Journal of infectious diseases, 2011, 204.suppl_1: S18-S23.
SATO, Ryoko, et al. Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria. Human Vaccines & Immunotherapeutics, 2022, 18.6: 2114697.
JANASZEK-SEYDLITZ, Wiesława. Odra w Polsce–badania seroepidemiologiczne. Państwowy Zakład Higieny, Warszawa, 2004.
WORLD HEALTH ORGANIZATION, et al. Early warning, alert and response to acute public health events in refugee-hosting countries: Ukraine crisis. World Health Organization. Regional Office for Europe, 2022.
BOJARSKA, Małgorzata, et al. ODRA: CHOROBA, KTÓRA POWRACA MEASLES: A DISEASE THAT’S MAKING A COMEBACK. 2022.
COOPER, Louis Z. The history and medical consequences of rubella. Clinical Infectious Diseases, 1985, 7.Supplement_1: S2-S10.
WINTER, Amy K.; MOSS, William J. Rubella. The Lancet, 2022, 399.10332: 1336-1346.
ABRAMCZUK, Edyta, et al. Problem of rubella in Poland after compensatory outbreak in 2013. Przegląd Epidemiologiczny, 2016, 549.
SUGISHITA, Yoshiyuki, et al. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012–2013 epidemics in Tokyo, Japan. Japanese Journal of Infectious Diseases, 2015, 68.2: 159-165.
COOPER, LOUIS Z., et al. Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero. American journal of diseases of children, 1965, 110.4: 416-427.
BOUTHRY, E., et al. Positive predictive value of seroconversion or positive rubella IgM in diagnosis of maternal rubella infection: seven-years review of French National Reference Laboratory for Rubella. Journal of Clinical Virology, 2021, 134: 104708.
Marshall HS, Plotkin S. The changing epidemiology of mumps in a high vaccination era. The Lancet Infectious Diseases. 2019 Feb 1;19(2):118-9.
Grant GB. Progress in rubella and congenital rubella syndrome control and elimination—worldwide, 2000–2016. MMWR. Morbidity and Mortality Weekly Report. 2017;66.
WHO. WHO vaccine-preventable diseases: monitoring system. 2020 global summary.
McNamara, L. A., Skoff, T., Faulkner, A., Miller, L., Kudish, K., Kenyon, C., Bargsten, M., Zansky, S., Sullivan, A. D., Martin, S., & Briere, E. (2017). Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination—United States, 2010–2012. Clinical Infectious Diseases, 65(5), 811-818. https://doi.org/10.1093/cid/cix421
Tuomanen E, Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985 Jul;152(1):118-25. doi: 10.1093/infdis/152.1.118. PMID: 2861240.
Guérin J, Bigot S, Schneider R, Buchanan SK, Jacob-Dubuisson F. Two-Partner Secretion: Combining Efficiency and Simplicity in the Secretion of Large Proteins for Bacteria-Host and Bacteria-Bacteria Interactions. Front Cell Infect Microbiol. 2017 May 9;7:148. doi: 10.3389/fcimb.2017.00148. PMID: 28536673; PMCID: PMC5422565.
Tuomanen E, Towbin H, Rosenfelder G, Braun D, Larson G, Hansson GC, Hill R. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med. 1988 Jul 1;168(1):267-77. doi: 10.1084/jem.168.1.267. PMID: 2899620; PMCID: PMC2188977.
Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH, Read RJ. The crystal structure of pertussis toxin. Structure. 1994 Jan 15;2(1):45-57. doi: 10.1016/s0969-2126(00)00007-1. PMID: 8075982.
Novak J, Cerny O, Osickova A, Linhartova I, Masin J, Bumba L, Sebo P, Osicka R. Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes. Toxins (Basel). 2017 Sep 24;9(10):300. doi: 10.3390/toxins9100300. PMID: 28946636; PMCID: PMC5666347.
Guiso N. Bordetella Adenylate Cyclase-Hemolysin Toxins. Toxins (Basel). 2017 Sep 11;9(9):277. doi: 10.3390/toxins9090277. PMID: 28892012; PMCID: PMC5618210.
Heiss LN, Moser SA, Unanue ER, Goldman WE. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect Immun. 1993 Aug;61(8):3123-8. doi: 10.1128/iai.61.8.3123-3128.1993. PMID: 8335342; PMCID: PMC280978.
Kessie DK, Lodes N, Oberwinkler H, Goldman WE, Walles T, Steinke M, Gross R. Activity of Tracheal Cytotoxin of Bordetella pertussis in a Human Tracheobronchial 3D Tissue Model. Front Cell Infect Microbiol. 2021 Jan 19;10:614994. doi: 10.3389/fcimb.2020.614994. PMID: 33585281; PMCID: PMC7873972.
Kuwae A, Matsuzawa T, Ishikawa N, Abe H, Nonaka T, Fukuda H, Imajoh-Ohmi S, Abe A. BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death. J Biol Chem. 2006 Mar 10;281(10):6589-600. doi: 10.1074/jbc.M512711200. Epub 2006 Jan 4. PMID: 16407269.
Kuwae A, Momose F, Nagamatsu K, Suyama Y, Abe A. BteA Secreted from the Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton Signaling Pathway and Inhibits Phagocytosis by Macrophages. PLoS One. 2016 Feb 1;11(2):e0148387. doi: 10.1371/journal.pone.0148387. Erratum in: PLoS One. 2017 Jun 22;12 (6):e0180287. PMID: 26828590; PMCID: PMC4734908.
Kilgore, P. E., Salim, A. M., Zervos, M. J., & Schmitt, J. (2016). Pertussis: Microbiology, Disease, Treatment, and Prevention. Clinical Microbiology Reviews, 29(3), 449-486. https://doi.org/10.1128/CMR.00083-15
Kline JM, Lewis WD, Smith EA, Tracy LR, Moerschel SK. Pertussis: a reemerging infection. Am Fam Physician. 2013 Oct 15;88(8):507-14. Erratum in: Am Fam Physician. 2014 Mar 1;89(5):317. Dosage error in article text. PMID: 24364571.
Kline JM, Smith EA, Zavala A. Pertussis: Common Questions and Answers. Am Fam Physician. 2021 Aug 1;104(2):186-192. PMID: 34383446.
Fry NK, Campbell H, Amirthalingam G. JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable. J Med Microbiol. 2021 Oct;70(10):001442. doi: 10.1099/jmm.0.001442. PMID: 34668853; PMCID: PMC8604168.
Jia J, Yuan L, Gao W, Yao KH. [Complications of pertussis]. Zhongguo Dang Dai Er Ke Za Zhi. 2019 Jul;21(7):713-717. Chinese. doi: 10.7499/j.issn.1008-8830.2019.07.018. PMID: 31315774; PMCID: PMC7389100.
Sanghi, V. (2013). Neurologic manifestations of diphtheria and pertussis. Handbook of Clinical Neurology, 121, 1355-1359. https://doi.org/10.1016/B978-0-7020-4088-7.00092-4
Wang J, Gao J, Fan H, Guo H, Yin Z, Dong M, Huang X. Multiple rib and vertebral fractures associated with Bordetella pertussis infection: a case report. BMC Infect Dis. 2023 Apr 6;23(1):212. doi: 10.1186/s12879-023-08189-w. PMID: 37024849; PMCID: PMC10080936.
Bhattacharya, D., Sharma, Y. K., Muralidharan, J., & Mathew, J. L. (2019). Spontaneous pneumothorax in an infant: An unusual complication of pertussis. BMJ Case Reports, 12(9). https://doi.org/10.1136/bcr-2019-231878
Alghounaim, M., Alsaffar, Z., Alfraij, A., Bin-Hasan, S., & Hussain, E. (2022). Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy. Medical Principles and Practice, 31(4), 313-321. https://doi.org/10.1159/000525468
Karolina, U. (2022). Krztusiec I „Efekt Czerwonej Królowej”. Postępy Mikrobiologii, 61(3), 133-145. https://doi.org/10.2478/am-2022-012
Komunikat Głównego Inspektora Sanitarnego z dnia 28 października 2023 r. w sprawie Programu Szczepień́ Ochronnych na rok 2024 (Dz.U. z 2023 r. poz. 1284, 909, 1938).
R.Whittaker, A. Economopoulou, J. Dias, E. Bancroft, M. Ramliden, L. Celentano, European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease, Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007–2014, Emerg Infect Dis, 23 (2017), pp. 396-404, 10.3201/eid2303.161552
Adriana Efron, Daniela Nápoli, Silvina Neyro, María del Valle Juárez, María Moscoloni, et.al., Laboratory surveillance of invasive Haemophilus influenzae disease in Argentina, 2011–2019, Revista Argentina de Microbiología, Volume 55, Issue 2, 2023, Pages 133-142, https://doi.org/10.1016/j.ram.2022.08.002.
Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy, Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Główny Inspektorat Sanitarny, Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic, Choroby Zakaźne i Zatrucia w Polsce w 2023 r., stan z dnia 29.03.2024
Slack MPE. Long Term Impact of Conjugate Vaccines on Haemophilus influenzae Meningitis: Narrative Review. Microorganisms. 2021; 9(5):886. https://doi.org/10.3390/microorganisms9050886
Okarska-Napierała M, Kuchar E., Zapalenie opon mózgowo-rdzeniowych u dzieci – postępowanie praktyczne, Standardy Medyczne/Pediatria, pages 241-250, 2017
Olarte, L.; Barson, W.J.; Barson, R.M.; Lin, P.L.; Romero, J.R.; Tan, T.Q.; Givner, L.B.; Bradley, J.S.; Hoffman, J.A.; Hultén, K.G.; et al. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin. Infect. Dis. 2015, 61, 767–775.
Baraff, L.J.; Lee, S.I.; Schriger, D.L. Outcome of Bacterial Meningitis in Children a Meta-Analysis. Pediatr. Infect. Dis. J. 1993, 12, 389–394.
Zainel A, Mitchell H, Sadarangani M. Bacterial Meningitis in Children: Neurological Complications, Associated Risk Factors, and Prevention. Microorganisms. 2021; 9(3):535. https://doi.org/10.3390/microorganisms9030535
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Izabela Sztybór, Klaudia Brygida Kułak, Karolina Alicja Palacz, Marzena Pliszka, Izabela Janik, Katarzyna Gadżała, Katarzyna Chamera-Cyrek, Anna Maria Koman, Martyna Kuśmierska, Sabina Przygodzka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 452
Number of citations: 0
